DCM Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:30 pm

Competitors of DCM Ltd

All Competitor Stocks of DCM Ltd

Quarterly Result

Last Updated: August 20, 2025, 11:45 am

Below is a detailed analysis of the quarterly data for DCM Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 17.61 Cr.. The value appears strong and on an upward trend. It has increased from 16.63 Cr. (Mar 2025) to 17.61 Cr., marking an increase of 0.98 Cr..
• For Expenses, as of Jun 2025, the value is 16.34 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.93 Cr. (Mar 2025) to 16.34 Cr., marking a decrease of 0.59 Cr..
• For Operating Profit, as of Jun 2025, the value is 1.27 Cr.. The value appears strong and on an upward trend. It has increased from -0.30 Cr. (Mar 2025) to 1.27 Cr., marking an increase of 1.57 Cr..
• For OPM %, as of Jun 2025, the value is 7.21%. The value appears strong and on an upward trend. It has increased from -1.80% (Mar 2025) to 7.21%, marking an increase of 9.01%.
• For Other Income, as of Jun 2025, the value is 3.86 Cr.. The value appears strong and on an upward trend. It has increased from 3.22 Cr. (Mar 2025) to 3.86 Cr., marking an increase of 0.64 Cr..
• For Interest, as of Jun 2025, the value is 0.28 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.31 Cr. (Mar 2025) to 0.28 Cr., marking a decrease of 0.03 Cr..
• For Depreciation, as of Jun 2025, the value is 0.97 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.91 Cr. (Mar 2025) to 0.97 Cr., marking an increase of 0.06 Cr..
• For Profit before tax, as of Jun 2025, the value is 3.88 Cr.. The value appears strong and on an upward trend. It has increased from 1.70 Cr. (Mar 2025) to 3.88 Cr., marking an increase of 2.18 Cr..
• For Tax %, as of Jun 2025, the value is 16.49%. The value appears to be improving (decreasing) as expected. It has decreased from 44.71% (Mar 2025) to 16.49%, marking a decrease of 28.22%.
• For Net Profit, as of Jun 2025, the value is 3.24 Cr.. The value appears strong and on an upward trend. It has increased from 0.94 Cr. (Mar 2025) to 3.24 Cr., marking an increase of 2.30 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.73. The value appears strong and on an upward trend. It has increased from 0.50 (Mar 2025) to 1.73, marking an increase of 1.23.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:28 am

Growth

Last Updated: September 5, 2025, 2:40 am

Balance Sheet

Last Updated: October 10, 2025, 1:53 pm

Below is a detailed analysis of the balance sheet data for DCM Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 19.00 Cr..
• For Reserves, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 22.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 81.00 Cr.. The value appears to be improving (decreasing). It has decreased from 91.00 Cr. (Mar 2024) to 81.00 Cr., marking a decrease of 10.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 125.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 113.00 Cr. (Mar 2024) to 125.00 Cr., marking an increase of 12.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2024) to 31.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 13.00 Cr..
• For Other Assets, as of Mar 2025, the value is 70.00 Cr.. The value appears strong and on an upward trend. It has increased from 68.00 Cr. (Mar 2024) to 70.00 Cr., marking an increase of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 125.00 Cr.. The value appears strong and on an upward trend. It has increased from 113.00 Cr. (Mar 2024) to 125.00 Cr., marking an increase of 12.00 Cr..

Notably, the Reserves (24.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for DCM Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 11.73, marking an increase of 8.94.
• For Diluted EPS (Rs.), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 11.73, marking an increase of 8.94.
• For Cash EPS (Rs.), as of Mar 25, the value is 3.24. This value is within the healthy range. It has decreased from 5.54 (Mar 24) to 3.24, marking a decrease of 2.30.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.98. It has increased from 11.12 (Mar 24) to 22.98, marking an increase of 11.86.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 22.98. It has increased from 11.12 (Mar 24) to 22.98, marking an increase of 11.86.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 36.96. It has decreased from 37.93 (Mar 24) to 36.96, marking a decrease of 0.97.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 5.65. This value is within the healthy range. It has decreased from 7.92 (Mar 24) to 5.65, marking a decrease of 2.27.
• For PBIT / Share (Rs.), as of Mar 25, the value is 3.45. This value is within the healthy range. It has decreased from 5.43 (Mar 24) to 3.45, marking a decrease of 1.98.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.47. This value is within the healthy range. It has decreased from 4.34 (Mar 24) to 2.47, marking a decrease of 1.87.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 2. It has decreased from 3.05 (Mar 24) to 1.04, marking a decrease of 2.01.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.73. This value is within the healthy range. It has increased from 2.79 (Mar 24) to 11.73, marking an increase of 8.94.
• For PBDIT Margin (%), as of Mar 25, the value is 15.29. This value is within the healthy range. It has decreased from 20.88 (Mar 24) to 15.29, marking a decrease of 5.59.
• For PBIT Margin (%), as of Mar 25, the value is 9.34. This value is below the healthy minimum of 10. It has decreased from 14.33 (Mar 24) to 9.34, marking a decrease of 4.99.
• For PBT Margin (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 10. It has decreased from 11.43 (Mar 24) to 6.69, marking a decrease of 4.74.
• For Net Profit Margin (%), as of Mar 25, the value is 2.80. This value is below the healthy minimum of 5. It has decreased from 8.05 (Mar 24) to 2.80, marking a decrease of 5.25.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 31.74. This value exceeds the healthy maximum of 20. It has increased from 7.34 (Mar 24) to 31.74, marking an increase of 24.40.
• For Return on Networth / Equity (%), as of Mar 25, the value is 51.07. This value is within the healthy range. It has increased from 25.06 (Mar 24) to 51.07, marking an increase of 26.01.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.79. This value is below the healthy minimum of 10. It has decreased from 19.78 (Mar 24) to 9.79, marking a decrease of 9.99.
• For Return On Assets (%), as of Mar 25, the value is 17.52. This value is within the healthy range. It has increased from 4.59 (Mar 24) to 17.52, marking an increase of 12.93.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.62 (Mar 24) to 0.57, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1.5. It has increased from 0.81 (Mar 24) to 0.91, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.67 (Mar 24) to 0.78, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.13 (Mar 24) to 0.00, marking a decrease of 0.13.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 5.77. This value is within the healthy range. It has decreased from 7.22 (Mar 24) to 5.77, marking a decrease of 1.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 3. It has decreased from 3.78 (Mar 24) to 2.06, marking a decrease of 1.72.
• For Enterprise Value (Cr.), as of Mar 25, the value is 152.25. It has increased from 111.71 (Mar 24) to 152.25, marking an increase of 40.54.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has increased from 1.58 (Mar 24) to 2.21, marking an increase of 0.63.
• For EV / EBITDA (X), as of Mar 25, the value is 14.42. This value is within the healthy range. It has increased from 7.55 (Mar 24) to 14.42, marking an increase of 6.87.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.62, marking an increase of 0.73.
• For Price / BV (X), as of Mar 25, the value is 4.22. This value exceeds the healthy maximum of 3. It has decreased from 6.45 (Mar 24) to 4.22, marking a decrease of 2.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 1.89 (Mar 24) to 2.62, marking an increase of 0.73.
• For EarningsYield, as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.12, marking an increase of 0.09.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness